The iCanCare Follow-Up Study

logo-icancare

CanSORT received a $13 million program award from the National Cancer Institute in 2012 to study the challenges of individualizing treatments for patients with breast cancer. This study seeks to better understand how women with breast cancer and their doctors decide on a variety of test and treatment options based on clinical and other factors.

The iCanCare Study involves surveys of selected women diagnosed with early stage breast cancer in the state of Georgia and Los Angeles County, California and their treating doctors – surgeons, medical oncologists, and radiation oncologists.  Women are surveyed approximately 6 months after their breast cancer diagnosis and asked about their decision making experiences regarding tests and treatments for their breast cancer.  Doctors are surveyed about their general perspectives and recommendations regarding breast cancer tests and treatments.

Individual patients and doctors cannot be identified in the study data and survey responses are never shared between patients and doctors.

Below are some frequently-asked questions about the I Can Care Study.  Please click on each topic to learn more.

Frequently Asked Questions